Press Releases :: CohBar, Inc. (CWBR)

CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy

The companies hosted a joint webcast on May 23, 2023, to discuss the transaction.

Morphogenesis Website

Access Webcast Replay

Nov 16, 2015 4:05pm EST

CohBar, Inc. Announces Third Quarter 2015 Financial Results

Nov 11, 2015 4:58pm EST

CohBar, Inc. To Announce 2015 Third Quarter Financial Results and Host Conference Call for Shareholders on November 16, 2015

Oct 06, 2015 3:00pm EDT

CohBar, Inc. Presentation Now Available for On-Demand Viewing

Sep 28, 2015 8:00am EDT

CohBar, Inc. to Webcast, Live, at VirtualInvestorConferences.com October 1

Sep 23, 2015 9:00am EDT

CohBar to Present at Upcoming Investor and Scientific Conferences

Aug 11, 2015 8:30am EDT

CohBar, Inc. Announces Second Quarter 2015 Financial Results

May 20, 2015 7:00am EDT

CohBar Announces Commencement of Trading on the OTCQX Marketplace

May 15, 2015 8:30am EDT

CohBar, Inc. Announces First Quarter 2015 Financial Results

Mar 31, 2015 9:00am EDT

CohBar, Inc. Announces Full Year 2014 Financial Results

Mar 03, 2015 12:09pm EST

CohBar, Inc. Announces Publication of Preclinical Proof-of-Principle of MOTS-c and its Role in Metabolic Regulation